Display Settings:

Format

Send to:

Choose Destination
    Am J Hematol. 2008 Aug;83(8):673-5.

    Late reactivation of resolved hepatitis B virus infection: an increasing complication post rituximab-based regimens treatment?

    Source

    Servicio de Hematologia, Hospital Universitario La Paz, Madrid, Spain. mj.garciarodriguez@gmail.com

    Abstract

    Reactivation of hepatitis B infection is an increasing problem for patients with lymphoma, even in resolved infections, who were treated with rituximab-based regimens. Our cases point out the need of prolonged prophylaxis in HBsAg-negative patients due to the high risk of developing fatal reactivation.

    Copyright 2008 Wiley-Liss, Inc.

    PMID:
    18528824
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for John Wiley & Sons, Inc.

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk